Allianz Asset Management Gmb H Ardelyx, Inc. Transaction History

Allianz Asset Management Gmb H

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$6.05 - $9.74 $687,885 - $1.11 Million	-113,700 Reduced 77.51%	33,000 $240,000
Q4 2023 Feb 12, 2024	BUY	$3.29 - $6.64 $482,643 - $974,088	146,700 New	146,700 $909,000
Q3 2021 Nov 10, 2021	SELL	$1.27 - $8.17 $36,214 - $232,967	-28,515 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$6.55 - $8.98 $1.6 Million - $2.2 Million	-244,635 Reduced 89.56%	28,515 $216,000
Q1 2021 May 13, 2021	BUY	$6.1 - $7.69 $551,501 - $695,252	90,410 Added 49.47%	273,150 $1.81 Million
Q3 2020 Nov 13, 2020	SELL	$5.25 - $7.08 $21,850 - $29,466	-4,162 Reduced 2.23%	182,740 $960,000
Q2 2020 Aug 14, 2020	BUY	$5.37 - $8.11 $705,945 - $1.07 Million	131,461 Added 237.12%	186,902 $1.29 Million
Q1 2020 May 14, 2020	BUY	$4.35 - $8.79 $241,168 - $487,326	55,441 New	55,441 $315,000

231

150M

1.54M

3.08M

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $779M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Allianz Asset Management Gmb H with notifications on news.